chronic obstructive pulmonary disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients who are diagnosed with moderate to severe AECOPD; (2) Patients who meet the Chinese medicine syndrome classification of phlegm heat obstructing lung; (3) Patients who are aged 40–80 years; (4) Patients who do not participate in other interventional trials in the past month; (5) Patients who sign the written informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients who are pregnant or lactating; (2) Patients who are unable to communicate; (3) Patients who have heart failure (NYHA Class IV), severe cardiac arrhythmias,or unstable hemodynamics; (4) Patients who have bronchiectasis, active tuberculosis, pneumothorax, pleural effusion, pulmonary thromboembolic, or neuromuscular diseases affecting respiratory movement function; (5) Patients who have a history of tumor; (6) Patients who have been treated for more than seven days outside the hospital; (7) Patients who require invasive mechanical ventilation; (8) Patients who have severe liver or kidney disease; (9) Patients who require long-term bed rest; (10) Patients who have known hypersensitivity to the study medication or some of its ingredients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration from admission to the time meeting discharge criteria;Clinical COPD questionnaire (CCQ); | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical symptoms and signs scores;mMRC;Frequency and severity of acute exacerbation;The time to the first acute exacerbation;COPD assessment test (CAT);mPRO-COPD;mESQ-COPD;Arterial blood gas analysis; | — |
Countries
China
Contacts
He'nan University of Chinese Medicine